Tyrian Dx, Becton Dickinson Unable to Develop TB Test, End Collaboration

The two firms were unable to detect a lead protein biomarker discovered by Tyrian at high enough sensitivity and specificity levels. Tyrian is now working with another organization to validate the biomarker in an effort to develop a molecular test.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories